Congenital Abnormality, Congenital Diaphragmatic Hernia
Conditions
Keywords
Congenital diaphragmatic hernia, Fetal anomalies
Brief summary
The neonatal mortality rate in cases with severe isolated congenital diaphragmatic hernia is higher than 90% due to severe pulmonary hypoplasia. Many studies have suggested that fetal tracheal occlusion may increase lung volumes and therefore reducing the risk for severe pulmonary hypoplasia and by consequence the risk for neonatal death. The main objective of the present study is to evaluate if fetal tracheal occlusion improves survival rate in those cases that are followed in our hospital, by conducing a randomized trial.
Detailed description
Fetuses will be randomly allocated in two groups: 1. for fetal tracheal occlusion at 26-28 weeks (FETO group) or 2. Postnatal therapy only (Control) Main outcome: Survival rate in both groups Second outcomes: Postnatal diagnosis of severe pulmonary arterial hypertension, percentage of newborns in each group that will have clinical conditions for neonatal surgical repair of the diaphragmatic defect, fetal lung responses (increase of fetal lung size), maternal and obstetrical complications (prematurity, preterm rupture of the membranes, maternal hemorrhage and infection).
Interventions
PROCEDUREFetal tracheal occlusion
Insertion of a detachable balloon inside fetal trachea by percutaneous fetoscopy
Sponsors
Ministry of Health, Brazil
University of Sao Paulo General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* ultrasound diagnosis of congenital diaphragmatic hernia * fetuses at gestational age between 24 and 28 weeks * absence of chromosomal and/or other structural anomalies (isolated congenital diaphragmatic hernia) * severe congenital diaphragmatic hernia defined by lung-head ratio \< 1.0 and more than 1/3 of liver herniated into fetal thorax and observed/expected fetal total lung volume \< 0.35 * patient's consent to participate in the present study
Exclusion criteria
* Patient's refusal to participate in the study after allocation * Preterm labor diagnosed before the procedure * Preterm rupture of membranes before fetal intervention
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survival rate | 1 year | Noenatal survival rate which includes percentage of newborns that survive up to 30 days of life. Infant survival rate which includes percentage of newborns that survive up to one year of life. Outcome measurement will be assessed up to one year after birth. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postnatal pulmonary arterial hypertension | 30 days of life | Postnatal pulmonary arterial hypertension will be assessed up to 30 days of life according to the echocardiographic findings. |
Countries
Brazil
Outcome results
None listed